MedTrace Logo

Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence

NCT06224166 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 283

Last updated 2024-01-26

No results posted yet for this study

Summary

Multicenter, non-interventional, retrospective/prospective biological study on patients affected by head and neck tumors, for which the collection and use of tissue samples, blood and saliva for the detection of HPV-DNA/RNA and miRNA.

Conditions

  • Head and Neck Tumors

Interventions

DIAGNOSTIC_TEST

Collection and use of tissue samples, blood and saliva

For tissue collection, tumor and surrounding tissues will be used healthy specimens taken during surgical removal, according to clinical practice. Blood and saliva sampling will be carried out at different times: i) the day before surgery; ii) the day after surgery (only for blood); iii) at the time of patient discharge (approximately 15 days after surgery); iii) during the check-up visit scheduled to monitor the follow-up (FU)

Sponsors & Collaborators

  • University of Milan

    collaborator OTHER

  • Istituti Tumori Giovanni Paolo II

    collaborator NETWORK

  • Regina Elena Cancer Institute

    lead OTHER

Principal Investigators

  • Giovanni Blandino, Doctor · IRCCS "Regina Elena" National Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-17
Primary Completion
2025-01-17
Completion
2025-01-17

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06224166 on ClinicalTrials.gov